Dapagliflozin vs Upadacitinib

Dapagliflozin vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Upadacitinib.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Upadacitinib — C17H19F3N6O.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Dapagliflozin — Small molecule; Upadacitinib — Small molecule.